Combined high expression of MAP17 and fascin-1 in colorectal cancer: Targeted therapy in need?

被引：0
|
作者：
Tampakis, A. [1 ]
Tampaki, E. [2 ]
Nonni, A. [3 ]
Bolli, M. [1 ]
von Flue, M. [1 ]
Felekouras, E. [4 ]
Nikiteas, N. [2 ]
机构：
[1] Univ Hosp Basel, Univ Ctr Gastrointestinal & Liver Dis, Clarunis, Basel, Switzerland
[2] Athens Univ, Laiko Gen Hosp, Dept Propedeut Surg 2, Sch Med, Athens, Greece
[3] Natl Univ Athens, Sch Med, Dept Pathol 1, Athens, Greece
[4] Athens Univ, Laiko Gen Hosp, Dept Surg 1, Sch Med, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-90
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [1] Combined expression of fascin-1 and MAP17 in colorectal cancer: A group of patients in high risk
    Tampaki, E. C.
    Nonni, A.
    von Fluee, M.
    Felekouras, E.
    Nikiteas, N.
    Tampakis, A.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (SUPPL 3)
  • [2] Combined expression of fascin-1 and MAP17 in colorectal cancer: A group of patients in high risk
    Tampaki, Ekaterini Christina
    Nonni, Afrodite
    von Fluee, Markus
    Felekouras, Evangelos
    Nikiteas, Nikolaos
    Tampakis, Athanasios
    SWISS MEDICAL WEEKLY, 2022, 152 : 31S - 31S
  • [3] Combined Fascin-1 and MAP17 Expression in Breast Cancer Identifies Patients with High Risk for Disease Recurrence
    Tampaki, Ekaterini Christina
    Tampakis, Athanasios
    Nonni, Afroditi
    von Flue, Markus
    Patsouris, Efstratios
    Kontzoglou, Konstantinos
    Kouraklis, Gregory
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (05) : 635 - 644
  • [4] Combined Fascin-1 and MAP17 Expression in Breast Cancer Identifies Patients with High Risk for Disease Recurrence
    Ekaterini Christina Tampaki
    Athanasios Tampakis
    Afroditi Nonni
    Markus von Flüe
    Efstratios Patsouris
    Konstantinos Kontzoglou
    Gregory Kouraklis
    Molecular Diagnosis & Therapy, 2019, 23 : 635 - 644
  • [5] Expression of fascin-1 and MAP17 in breast cancer identifies high risk patients prone to disease recurrence and/or metastasis
    Tampakis, A.
    Tampaki, E. C.
    Nonni, A.
    Kontzoglou, K.
    Kouraklis, G.
    BREAST, 2019, 44 : S30 - S30
  • [6] High Expression of Both Resistin and Fascin-1 Predicts a Poor Prognosis in Patients with Colorectal Cancer
    Wang, Chao-Qun
    Wang, Yan
    Huang, Bi-Fei
    Tang, Chih-Hsin
    Du, Zhang
    Zeng, Yue
    Wang, Qian
    Shao, Jun-Kang
    Jin, Lu-Lu
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [7] Immunohistochemical expression of Fascin-1 in colorectal cancer in relation to clinical and pathological parameters
    Piskor, Barbara M.
    Pryczynicz, Anna
    Lubowicka, Emilia
    Miniewska, Katarzyna
    Zinczuk, Justyna
    Zareba, Konrad
    Guzinska-Ustymowicz, Katarzyna
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2018, 56 (02) : 106 - 112
  • [8] Prognostic Impact of Fascin-1 Expression is More Significant in Advanced Colorectal Cancer
    Oh, Seung Yeop
    Kim, Young Bae
    Suh, Kwang Wook
    Paek, Ok Joo
    Moon, Hong Young
    JOURNAL OF SURGICAL RESEARCH, 2012, 172 (01) : 102 - 108
  • [9] Fascin-1 as a biomarker and prospective therapeutic target in colorectal cancer
    Adams, Josephine C.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (01) : 41 - 48
  • [10] High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality
    Athanasios, Tampakis
    Ekaterini-Christina, Tampaki
    Afrodite, Nonni
    Ioannis, Kostakis D.
    Alberto, Posabella
    Konstantinos, Kontzoglou
    Markus, von Flue
    Evangelos, Felekouras
    Gregory, Kouraklis
    Nikolaos, Nikiteas
    BMC CANCER, 2021, 21 (01)
12345